Stimcell Energetics (STME) Total Non-Current Liabilities (2019)
Stimcell Energetics' (STME) quarterly Total Non-Current Liabilities came in at $1.2 million in Q3 2019, down 36.79% quarter-over-quarter from $2.0 million in Q2 2019.
Stimcell Energetics (STME) Total Non-Current Liabilities (2019) Analysis & Trends
Stimcell Energetics' Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $1.2 million for Q3 2019.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $1.2 million in Q3 2019; TTM through Aug 2019 was $1.2 million, a N/A change from a year earlier, with the FY2019 full-year figure at $2.0 million, changed N/A from the prior year.
- Total Non-Current Liabilities retreated to $1.2 million in Q3 2019 per STME's latest filing, from $2.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $2.0 million in Q2 2019 and bottomed at $1.2 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2019 | 1.24 Mn |
| May 31, 2019 | 1.96 Mn |